Results: 57

La aspirina sería igual de efectiva que la warfarina en la prevención de eventos tromboembólicos luego del reemplazo valvular aórtico con bioprótesis
Aspirin could be as effective as warfarin in the prevention of thromboembolic events after aortic valve replacement with a bioprosthesis

Uninterrupted Use of Oral Anticoagulants for the Ablation of Atrial Flutter: A Single Center Cohort of 154 Patients

Arq. bras. cardiol; 110 (2), 2018
Abstract Background: The uninterrupted use of oral anticoagulation (OAC) with vitamin K antagonists (VKAs) for electrophysiology procedures has been more and more recommended. The clinical practice in our service recommends the continuous use of these drugs for atrial flutter ablation. There is little e...

Anticoagulation in patients with cardiac manifestations of Chagas disease and cardioembolic ischemic stroke

Arq. neuropsiquiatr; 76 (1), 2018
ABSTRACT Objectives To describe anticoagulation characteristics in patients with cardiac complications from Chagas disease and compare participants with and without cardioembolic ischemic stroke (CIS). Methods A retrospective cohort of patients with Chagas disease, using anticoagulation, conducted fr...

Efeito do acompanhamento telefônico na qualidade de vida relacionada à saúde de pacientes nos primeiros seis meses de uso da varfarina: ensaio clínico aleatorizado

A varfarina é um anticoagulante oral, antivitamina K, amplamente utilizado na prevenção de trombos intravasculares de diferentes etiologias. Exige um controle rigoroso e complexo em decorrência da sua interação com outros fármacos e alimentos, o que pode interferir na Qualidade de Vida Relacionada...

Evaluación de la estrategia de terapia antitrombótica posterior al cambio valvular aórtico con válvulas biológicas en pacientes de bajo riesgo trombótico

Arch. cardiol. Méx; 88 (5), 2018
Resumen De acuerdo a las guías actuales, aún es materia de debate el uso de anticoagulación en los primeros 3 meses en pacientes de bajo riesgo trombótico sometidos a cambio valvular aórtico con prótesis biológicas. En base a la evidencia actual, la aspirina a dosis bajas es razonable como alterna...

Efectividad y seguridad del tratamiento anticoagulante con acenocumarol en fibrilación auricular no valvular

Rev. méd. Chile; 145 (10), 2017
Background: Vitamin K antagonists significantly decrease the incidence of stroke but increase the risk of bleeding. Aim: To assess the effectiveness and risk of bleeding of vitamin K antagonists in non-valvular atrial fibrillation. Material and Methods: Retrospective cohort study of 524 patients, 236 w...

Rivaroxaban para el tratamiento de la trombocitopenia inducida por heparina: caso clínico

Rev. méd. Chile; 145 (9), 2017
Heparin-induced thrombocytopenia (HIT) is immune-mediated. It occurs more frequently with unfractionated heparin (UFH) than with low molecular weight heparins (LMWH). It is associated with thromboembolic rather than hemorrhagic events, as opposed to thrombocytopenia of other etiologies. The key in therap...

Thromboembolism and bleeding risk scores and predictors of cardiac death in a population with atrial fibrillation

Arq. bras. cardiol; 109 (1), 2017
Abstract Background: Atrial fibrillation (AF) is a common arrhythmia, with risk of systemic embolism and death. It presents rheumatic etiology in up to 32% of developing countries, whose anticoagulation and evolution data are scarce. Objectives: to determine the predictors of cardiac death considering ...